Davidson Trust Company’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Sell
43,036
-11,724
-21% -$307K 0.4% 67
2026
Q1
$1.54M Buy
54,760
+10,107
+23% +$269K 0.66% 38
2025
Q4
$1.11M Buy
44,653
+3,997
+10% +$101K 0.46% 61
2025
Q3
$1.04M Buy
40,656
+224
+0.6% +$5.53K 0.43% 60
2025
Q2
$980K Sell
40,432
-6,172
-13% -$144K 0.45% 60
2025
Q1
$1.18M Buy
46,604
+6,948
+18% +$182K 0.56% 50
2024
Q4
$1.05M Buy
39,656
+5,062
+15% +$137K 0.54% 50
2024
Q3
$1M Buy
34,594
+1,915
+6% +$55.9K 0.51% 51
2024
Q2
$914K Buy
32,679
+11,512
+54% +$317K 0.63% 47
2024
Q1
$587K Buy
21,167
+6,424
+44% +$178K 0.34% 77
2023
Q4
$424K Buy
14,743
+815
+6% +$24.6K 0.27% 91
2023
Q3
$462K Buy
13,928
+17
+0.1% +$601 0.34% 75
2023
Q2
$510K Sell
13,911
-105
-0.7% -$4.09K 0.37% 66
2023
Q1
$572K Buy
14,016
+3,473
+33% +$150K 0.44% 58
2022
Q4
$540K Sell
10,543
-721
-6% -$34.6K 0.48% 57
2022
Q3
$493K Sell
11,264
-2,001
-15% -$97.2K 0.47% 60
2022
Q2
$696K Sell
13,265
-700
-5% -$35.7K 0.62% 43
2022
Q1
$723K Buy
13,965
+1,519
+12% +$78.8K 0.54% 52
2021
Q4
$735K Hold
12,446
0.5% 58
2021
Q3
$536K Sell
12,446
-2
-0% -$89 0.41% 64
2021
Q2
$488K Hold
12,448
0.38% 73
2021
Q1
$450K Sell
12,448
-643
-5% -$22.8K 0.38% 73
2020
Q4
$481K Sell
13,091
-8,180
-38% -$300K 0.41% 66
2020
Q3
$739K Hold
21,271
0.67% 44
2020
Q2
$659K Buy
21,271
+2,216
+12% +$75.3K 0.64% 47
2020
Q1
$589K Sell
19,055
-348
-2% -$11.9K 0.73% 40
2019
Q4
$721K Buy
+19,403
New +$691K 0.73% 43

Other funds holding PFE

Davidson Trust Company's PFE Position: Q2 2026 in Review

Davidson Trust Company reduced its Pfizer (PFE) stake by 21% in Q2 2026, selling an estimated $307K and leaving 43,036 shares worth $1.04M. The position accounts for 0.4% of the portfolio, ranked #67.

Davidson Trust Company first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.54M in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Davidson Trust Company held 43,036 shares of Pfizer worth $1.04M as of Q2 2026.
  • Davidson Trust Company sold 11,724 Pfizer shares in Q2 2026, an estimated $307K.
  • Pfizer made up 0.4% of Davidson Trust Company's portfolio in Q2 2026, its #67 holding.
  • Davidson Trust Company first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • Davidson Trust Company's Pfizer position peaked at $1.54M in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Davidson Trust Company's 13F filing for Q2 2026, filed 29 Jul 2026.